Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

526 results
  1. ... Hodgkin lymphoma is stage III or stage IV . Advanced favorable Hodgkin lymphoma means that the patient has 0–3 of ... Hodgkin Lymphoma Treatment Option Overview Treatment of Early Favorable ... of Advanced Classic Hodgkin Lymphoma Treatment of Recurrent Classic Hodgkin ...
  2. ... to bleomycin.[ 8 ] Table 3. Treatment Options for Hodgkin Lymphoma View in own ... classic HL Chemotherapy Recurrent classic HL Pembrolizumab or ...
  3. ... adapted therapy with ABVE [ 66 ] for patients with favorable low-stage disease and dose-dense ABVE-PC for patients with unfavorable advanced-stage disease in combination with 21 Gy IFRT.[ 21 ] Children and adolescents with low-risk Hodgkin lymphoma (stages I, IIA, IIIA1) treated with IFRT (25. ...
  4. ... wait policy versus immediate systemic treatment for asymptomatic advanced-stage ... IV non-Hodgkin's lymphomas of favorable histologic types. Ann Intern Med 90 (1): 10- ...
  5. ... wait policy versus immediate systemic treatment for asymptomatic advanced-stage ... IV non-Hodgkin's lymphomas of favorable histologic types. Ann Intern Med 90 (1): 10- ...
  6. ... al. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with ... Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma’. N Engl J Med 1993; 328:1002-1006 – ...
  7. ... wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. Lancet. 2003; 362 (9383): ...
  8. ... inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, ... inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, ...
  9. ... Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children's Oncology Group ... Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children's Oncology Group ...
  10. NLM Digital Collections - Drugs against cancer : stories of discovery and the quest for a cure 
    Publication: Bethesda, Maryland : National Cancer Institute, [2022]
    ... 3 Figure 13.7. Survival of patients with advanced Hodgkin lymphoma was increased by adding a bleomycin- and doxorubicin- ... was one of the first cancers at an advanced stage that could usually be ... of Hodgkin lymphoma patients. A major problem however was bleomycin-induced ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last